Loading…

Immunohistochemical differentiation of reactive from malignant mesothelium as a diagnostic aid in canine pericardial disease

Objectives To develop a provisional immunohistochemistry panel for distinguishing reactive pericardium, atypical mesothelial proliferation and mesothelioma in dogs. Materials and Methods Archived pericardial biopsies were subject to haematoxylin and eosin staining, immunohistochemistry for cytokerat...

Full description

Saved in:
Bibliographic Details
Published in:Journal of small animal practice 2018-05, Vol.59 (5), p.261-271
Main Authors: Milne, E., Martinez Pereira, Y., Muir, C., Scase, T., Shaw, D. J., McGregor, G., Oldroyd, L., Scurrell, E., Martin, M., Devine, C., Hodgkiss‐Geere, H.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3930-3a0a8d3d96dbf660345362d56d486672e5edae1e5737ecb39ad8858eb29bff63
cites cdi_FETCH-LOGICAL-c3930-3a0a8d3d96dbf660345362d56d486672e5edae1e5737ecb39ad8858eb29bff63
container_end_page 271
container_issue 5
container_start_page 261
container_title Journal of small animal practice
container_volume 59
creator Milne, E.
Martinez Pereira, Y.
Muir, C.
Scase, T.
Shaw, D. J.
McGregor, G.
Oldroyd, L.
Scurrell, E.
Martin, M.
Devine, C.
Hodgkiss‐Geere, H.
description Objectives To develop a provisional immunohistochemistry panel for distinguishing reactive pericardium, atypical mesothelial proliferation and mesothelioma in dogs. Materials and Methods Archived pericardial biopsies were subject to haematoxylin and eosin staining, immunohistochemistry for cytokeratin, vimentin, insulin‐like growth factor II mRNA‐binding protein 3, glucose transporter 1 and desmin. Samples were scored for intensity and number of cells stained. Results Ten biopsies of reactive mesothelium, 17 of atypical mesothelial proliferation, 26 of mesothelioma and five of normal pericardium were identified on the basis of haematoxylin and eosin staining. Cytokeratin and vimentin were expressed in all biopsies, confirming mesothelial origin. Normal pericardial samples had the lowest scores for insulin‐like growth factor II mRNA‐binding protein 3, glucose transporter 1 and desmin. Mesothelioma and atypical proliferative samples were similar to each other, with higher scores for insulin‐like growth factor II mRNA‐binding protein 3 and glucose transporter 1 than the reactive samples. Desmin staining was variable. Insulin‐like growth factor II mRNA‐binding protein 3 was the best to distinguish between disease groups. Clinical Significance An immunohistochemistry panel of cytokeratin, vimentin, insulin‐like growth factor II mRNA‐binding protein 3 and glucose transporter 1 could provide superior information compared with haematoxylin and eosin staining alone in the diagnosis of cases of mesothelial proliferation in canine pericardium, but further validation is warranted.
doi_str_mv 10.1111/jsap.12830
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2020892163</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2020892163</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3930-3a0a8d3d96dbf660345362d56d486672e5edae1e5737ecb39ad8858eb29bff63</originalsourceid><addsrcrecordid>eNp9kc9rFTEQx4Mo9lm9-AdIwIsUtubHJps9lqK1UlCw92U2me3LY5M8k91KwT_ePF_14MFchjCf-czAl5DXnJ3z-t7vCuzPuTCSPSEb3rWmUUZ0T8mGMSGaVnF2Ql6Usqtf3XbsOTkRvWadYv2G_LwOYY1p68uS7BaDtzBT56cJM8bFw-JTpGmiGcEu_h7plFOgAWZ_FyEuNGBJyxZnvwYKhUKdhbuYyuItBe-oj9RC9BHpHnOV59o_LCgIBV-SZxPMBV891lNy-_HD7eWn5ubL1fXlxU1jZS9ZI4GBcdL12o2T1ky2SmrhlHat0boTqNABclSd7NCOsgdnjDI4in6cJi1Pybujdp_T9xXLMgRfLM4zRExrGQQTzPSCa1nRt_-gu7TmWI-rlJTaKM77Sp0dKZtTKRmnYZ99gPwwcDYcIhkOkQy_I6nwm0flOgZ0f9E_GVSAH4EffsaH_6iGz98uvh6lvwBBeZiS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2033685119</pqid></control><display><type>article</type><title>Immunohistochemical differentiation of reactive from malignant mesothelium as a diagnostic aid in canine pericardial disease</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Milne, E. ; Martinez Pereira, Y. ; Muir, C. ; Scase, T. ; Shaw, D. J. ; McGregor, G. ; Oldroyd, L. ; Scurrell, E. ; Martin, M. ; Devine, C. ; Hodgkiss‐Geere, H.</creator><creatorcontrib>Milne, E. ; Martinez Pereira, Y. ; Muir, C. ; Scase, T. ; Shaw, D. J. ; McGregor, G. ; Oldroyd, L. ; Scurrell, E. ; Martin, M. ; Devine, C. ; Hodgkiss‐Geere, H.</creatorcontrib><description>Objectives To develop a provisional immunohistochemistry panel for distinguishing reactive pericardium, atypical mesothelial proliferation and mesothelioma in dogs. Materials and Methods Archived pericardial biopsies were subject to haematoxylin and eosin staining, immunohistochemistry for cytokeratin, vimentin, insulin‐like growth factor II mRNA‐binding protein 3, glucose transporter 1 and desmin. Samples were scored for intensity and number of cells stained. Results Ten biopsies of reactive mesothelium, 17 of atypical mesothelial proliferation, 26 of mesothelioma and five of normal pericardium were identified on the basis of haematoxylin and eosin staining. Cytokeratin and vimentin were expressed in all biopsies, confirming mesothelial origin. Normal pericardial samples had the lowest scores for insulin‐like growth factor II mRNA‐binding protein 3, glucose transporter 1 and desmin. Mesothelioma and atypical proliferative samples were similar to each other, with higher scores for insulin‐like growth factor II mRNA‐binding protein 3 and glucose transporter 1 than the reactive samples. Desmin staining was variable. Insulin‐like growth factor II mRNA‐binding protein 3 was the best to distinguish between disease groups. Clinical Significance An immunohistochemistry panel of cytokeratin, vimentin, insulin‐like growth factor II mRNA‐binding protein 3 and glucose transporter 1 could provide superior information compared with haematoxylin and eosin staining alone in the diagnosis of cases of mesothelial proliferation in canine pericardium, but further validation is warranted.</description><identifier>ISSN: 0022-4510</identifier><identifier>EISSN: 1748-5827</identifier><identifier>DOI: 10.1111/jsap.12830</identifier><identifier>PMID: 29607509</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Animals ; Biomarkers, Tumor ; Biopsy ; Cell Proliferation ; Cytokeratin ; Desmin ; Diagnosis, Differential ; Dog Diseases - diagnosis ; Dogs ; Female ; Glucose ; Glucose transporter ; Growth factors ; Immunohistochemistry ; Immunohistochemistry - veterinary ; Insulin ; Lung Neoplasms - diagnosis ; Lung Neoplasms - veterinary ; Male ; Mesothelioma ; Mesothelioma - diagnosis ; Mesothelioma - veterinary ; Mesothelioma, Malignant ; Mesothelium ; mRNA ; Pericarditis - diagnosis ; Pericarditis - veterinary ; Pericardium ; Pericardium - pathology ; Protein transport ; Proteins ; Retrospective Studies ; Vimentin</subject><ispartof>Journal of small animal practice, 2018-05, Vol.59 (5), p.261-271</ispartof><rights>2018 British Small Animal Veterinary Association</rights><rights>2018 British Small Animal Veterinary Association.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3930-3a0a8d3d96dbf660345362d56d486672e5edae1e5737ecb39ad8858eb29bff63</citedby><cites>FETCH-LOGICAL-c3930-3a0a8d3d96dbf660345362d56d486672e5edae1e5737ecb39ad8858eb29bff63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29607509$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Milne, E.</creatorcontrib><creatorcontrib>Martinez Pereira, Y.</creatorcontrib><creatorcontrib>Muir, C.</creatorcontrib><creatorcontrib>Scase, T.</creatorcontrib><creatorcontrib>Shaw, D. J.</creatorcontrib><creatorcontrib>McGregor, G.</creatorcontrib><creatorcontrib>Oldroyd, L.</creatorcontrib><creatorcontrib>Scurrell, E.</creatorcontrib><creatorcontrib>Martin, M.</creatorcontrib><creatorcontrib>Devine, C.</creatorcontrib><creatorcontrib>Hodgkiss‐Geere, H.</creatorcontrib><title>Immunohistochemical differentiation of reactive from malignant mesothelium as a diagnostic aid in canine pericardial disease</title><title>Journal of small animal practice</title><addtitle>J Small Anim Pract</addtitle><description>Objectives To develop a provisional immunohistochemistry panel for distinguishing reactive pericardium, atypical mesothelial proliferation and mesothelioma in dogs. Materials and Methods Archived pericardial biopsies were subject to haematoxylin and eosin staining, immunohistochemistry for cytokeratin, vimentin, insulin‐like growth factor II mRNA‐binding protein 3, glucose transporter 1 and desmin. Samples were scored for intensity and number of cells stained. Results Ten biopsies of reactive mesothelium, 17 of atypical mesothelial proliferation, 26 of mesothelioma and five of normal pericardium were identified on the basis of haematoxylin and eosin staining. Cytokeratin and vimentin were expressed in all biopsies, confirming mesothelial origin. Normal pericardial samples had the lowest scores for insulin‐like growth factor II mRNA‐binding protein 3, glucose transporter 1 and desmin. Mesothelioma and atypical proliferative samples were similar to each other, with higher scores for insulin‐like growth factor II mRNA‐binding protein 3 and glucose transporter 1 than the reactive samples. Desmin staining was variable. Insulin‐like growth factor II mRNA‐binding protein 3 was the best to distinguish between disease groups. Clinical Significance An immunohistochemistry panel of cytokeratin, vimentin, insulin‐like growth factor II mRNA‐binding protein 3 and glucose transporter 1 could provide superior information compared with haematoxylin and eosin staining alone in the diagnosis of cases of mesothelial proliferation in canine pericardium, but further validation is warranted.</description><subject>Animals</subject><subject>Biomarkers, Tumor</subject><subject>Biopsy</subject><subject>Cell Proliferation</subject><subject>Cytokeratin</subject><subject>Desmin</subject><subject>Diagnosis, Differential</subject><subject>Dog Diseases - diagnosis</subject><subject>Dogs</subject><subject>Female</subject><subject>Glucose</subject><subject>Glucose transporter</subject><subject>Growth factors</subject><subject>Immunohistochemistry</subject><subject>Immunohistochemistry - veterinary</subject><subject>Insulin</subject><subject>Lung Neoplasms - diagnosis</subject><subject>Lung Neoplasms - veterinary</subject><subject>Male</subject><subject>Mesothelioma</subject><subject>Mesothelioma - diagnosis</subject><subject>Mesothelioma - veterinary</subject><subject>Mesothelioma, Malignant</subject><subject>Mesothelium</subject><subject>mRNA</subject><subject>Pericarditis - diagnosis</subject><subject>Pericarditis - veterinary</subject><subject>Pericardium</subject><subject>Pericardium - pathology</subject><subject>Protein transport</subject><subject>Proteins</subject><subject>Retrospective Studies</subject><subject>Vimentin</subject><issn>0022-4510</issn><issn>1748-5827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kc9rFTEQx4Mo9lm9-AdIwIsUtubHJps9lqK1UlCw92U2me3LY5M8k91KwT_ePF_14MFchjCf-czAl5DXnJ3z-t7vCuzPuTCSPSEb3rWmUUZ0T8mGMSGaVnF2Ql6Usqtf3XbsOTkRvWadYv2G_LwOYY1p68uS7BaDtzBT56cJM8bFw-JTpGmiGcEu_h7plFOgAWZ_FyEuNGBJyxZnvwYKhUKdhbuYyuItBe-oj9RC9BHpHnOV59o_LCgIBV-SZxPMBV891lNy-_HD7eWn5ubL1fXlxU1jZS9ZI4GBcdL12o2T1ky2SmrhlHat0boTqNABclSd7NCOsgdnjDI4in6cJi1Pybujdp_T9xXLMgRfLM4zRExrGQQTzPSCa1nRt_-gu7TmWI-rlJTaKM77Sp0dKZtTKRmnYZ99gPwwcDYcIhkOkQy_I6nwm0flOgZ0f9E_GVSAH4EffsaH_6iGz98uvh6lvwBBeZiS</recordid><startdate>201805</startdate><enddate>201805</enddate><creator>Milne, E.</creator><creator>Martinez Pereira, Y.</creator><creator>Muir, C.</creator><creator>Scase, T.</creator><creator>Shaw, D. J.</creator><creator>McGregor, G.</creator><creator>Oldroyd, L.</creator><creator>Scurrell, E.</creator><creator>Martin, M.</creator><creator>Devine, C.</creator><creator>Hodgkiss‐Geere, H.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201805</creationdate><title>Immunohistochemical differentiation of reactive from malignant mesothelium as a diagnostic aid in canine pericardial disease</title><author>Milne, E. ; Martinez Pereira, Y. ; Muir, C. ; Scase, T. ; Shaw, D. J. ; McGregor, G. ; Oldroyd, L. ; Scurrell, E. ; Martin, M. ; Devine, C. ; Hodgkiss‐Geere, H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3930-3a0a8d3d96dbf660345362d56d486672e5edae1e5737ecb39ad8858eb29bff63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Biomarkers, Tumor</topic><topic>Biopsy</topic><topic>Cell Proliferation</topic><topic>Cytokeratin</topic><topic>Desmin</topic><topic>Diagnosis, Differential</topic><topic>Dog Diseases - diagnosis</topic><topic>Dogs</topic><topic>Female</topic><topic>Glucose</topic><topic>Glucose transporter</topic><topic>Growth factors</topic><topic>Immunohistochemistry</topic><topic>Immunohistochemistry - veterinary</topic><topic>Insulin</topic><topic>Lung Neoplasms - diagnosis</topic><topic>Lung Neoplasms - veterinary</topic><topic>Male</topic><topic>Mesothelioma</topic><topic>Mesothelioma - diagnosis</topic><topic>Mesothelioma - veterinary</topic><topic>Mesothelioma, Malignant</topic><topic>Mesothelium</topic><topic>mRNA</topic><topic>Pericarditis - diagnosis</topic><topic>Pericarditis - veterinary</topic><topic>Pericardium</topic><topic>Pericardium - pathology</topic><topic>Protein transport</topic><topic>Proteins</topic><topic>Retrospective Studies</topic><topic>Vimentin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Milne, E.</creatorcontrib><creatorcontrib>Martinez Pereira, Y.</creatorcontrib><creatorcontrib>Muir, C.</creatorcontrib><creatorcontrib>Scase, T.</creatorcontrib><creatorcontrib>Shaw, D. J.</creatorcontrib><creatorcontrib>McGregor, G.</creatorcontrib><creatorcontrib>Oldroyd, L.</creatorcontrib><creatorcontrib>Scurrell, E.</creatorcontrib><creatorcontrib>Martin, M.</creatorcontrib><creatorcontrib>Devine, C.</creatorcontrib><creatorcontrib>Hodgkiss‐Geere, H.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of small animal practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Milne, E.</au><au>Martinez Pereira, Y.</au><au>Muir, C.</au><au>Scase, T.</au><au>Shaw, D. J.</au><au>McGregor, G.</au><au>Oldroyd, L.</au><au>Scurrell, E.</au><au>Martin, M.</au><au>Devine, C.</au><au>Hodgkiss‐Geere, H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunohistochemical differentiation of reactive from malignant mesothelium as a diagnostic aid in canine pericardial disease</atitle><jtitle>Journal of small animal practice</jtitle><addtitle>J Small Anim Pract</addtitle><date>2018-05</date><risdate>2018</risdate><volume>59</volume><issue>5</issue><spage>261</spage><epage>271</epage><pages>261-271</pages><issn>0022-4510</issn><eissn>1748-5827</eissn><abstract>Objectives To develop a provisional immunohistochemistry panel for distinguishing reactive pericardium, atypical mesothelial proliferation and mesothelioma in dogs. Materials and Methods Archived pericardial biopsies were subject to haematoxylin and eosin staining, immunohistochemistry for cytokeratin, vimentin, insulin‐like growth factor II mRNA‐binding protein 3, glucose transporter 1 and desmin. Samples were scored for intensity and number of cells stained. Results Ten biopsies of reactive mesothelium, 17 of atypical mesothelial proliferation, 26 of mesothelioma and five of normal pericardium were identified on the basis of haematoxylin and eosin staining. Cytokeratin and vimentin were expressed in all biopsies, confirming mesothelial origin. Normal pericardial samples had the lowest scores for insulin‐like growth factor II mRNA‐binding protein 3, glucose transporter 1 and desmin. Mesothelioma and atypical proliferative samples were similar to each other, with higher scores for insulin‐like growth factor II mRNA‐binding protein 3 and glucose transporter 1 than the reactive samples. Desmin staining was variable. Insulin‐like growth factor II mRNA‐binding protein 3 was the best to distinguish between disease groups. Clinical Significance An immunohistochemistry panel of cytokeratin, vimentin, insulin‐like growth factor II mRNA‐binding protein 3 and glucose transporter 1 could provide superior information compared with haematoxylin and eosin staining alone in the diagnosis of cases of mesothelial proliferation in canine pericardium, but further validation is warranted.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>29607509</pmid><doi>10.1111/jsap.12830</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-4510
ispartof Journal of small animal practice, 2018-05, Vol.59 (5), p.261-271
issn 0022-4510
1748-5827
language eng
recordid cdi_proquest_miscellaneous_2020892163
source Wiley-Blackwell Read & Publish Collection
subjects Animals
Biomarkers, Tumor
Biopsy
Cell Proliferation
Cytokeratin
Desmin
Diagnosis, Differential
Dog Diseases - diagnosis
Dogs
Female
Glucose
Glucose transporter
Growth factors
Immunohistochemistry
Immunohistochemistry - veterinary
Insulin
Lung Neoplasms - diagnosis
Lung Neoplasms - veterinary
Male
Mesothelioma
Mesothelioma - diagnosis
Mesothelioma - veterinary
Mesothelioma, Malignant
Mesothelium
mRNA
Pericarditis - diagnosis
Pericarditis - veterinary
Pericardium
Pericardium - pathology
Protein transport
Proteins
Retrospective Studies
Vimentin
title Immunohistochemical differentiation of reactive from malignant mesothelium as a diagnostic aid in canine pericardial disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A42%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunohistochemical%20differentiation%20of%20reactive%20from%20malignant%20mesothelium%20as%20a%20diagnostic%20aid%20in%20canine%20pericardial%20disease&rft.jtitle=Journal%20of%20small%20animal%20practice&rft.au=Milne,%20E.&rft.date=2018-05&rft.volume=59&rft.issue=5&rft.spage=261&rft.epage=271&rft.pages=261-271&rft.issn=0022-4510&rft.eissn=1748-5827&rft_id=info:doi/10.1111/jsap.12830&rft_dat=%3Cproquest_cross%3E2020892163%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3930-3a0a8d3d96dbf660345362d56d486672e5edae1e5737ecb39ad8858eb29bff63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2033685119&rft_id=info:pmid/29607509&rfr_iscdi=true